Northern Ireland pharmaceutical firm Almac to create 229 new jobs
A Co Armagh-based pharmaceutical firm is to expand its business with the creation of 229 new jobs.
Almac is set to grow its operation with a £13.7 million investment in two areas of its business.
The company - headquartered in Craigavon - will develop a new facility alongside plans to expand its reach into export markets.
Almac provides services to more than 600 companies - including world leaders in the pharmaceutical and biotech sectors.
The firm's Graeme McBurney said the "centralising and expanding" of the production facility would mean "more cost effective manufacturing and optimal quality control and distribution".
"The added manufacturing capability will enable us to operate with improved speed and efficiency, particularly in the early stages of projects," he said.
"Ultimately, the investment will make Almac an even more attractive proposition to international clients who seek streamlined, one stop drug development solutions."
According to jobs minister Arlene Foster, the new positions will create almost £6 million in annual salaries.
The Almac group has expanded further in the last year and is now one of the 10 largest private sector businesses controlled from Northern Ireland.
In addition to Craigavon, the group has also invested large sums in a North American headquarters in Pennsylvania.
In the last five years total capital investment has exceeded £120m.
The latest employment boost is being backed up by £2 million of support from Invest NI.
The announcement comes after the Northern Ireland's credentials as a tech-hub were bolstered with several big IT jobs boosts - with US-owned Allstate creating 650 positions alone.